Stratasys Ltd 6-K, filed Mar 5, 2026
Stratasys Ltd. (SSYS)
6-K
2026-03-05
For: 2025-12-31
View Original
Added on
April 12, 2026
About this 6-K
Stratasys Ltd filed this 6-K on March 5, 2026.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of March 2026
Commission File Number 001-35751
STRATASYS LTD.
(Translation of registrant’s name into English)
| c/o Stratasys, Inc. 5995 Opus Parkway Minnetonka, Minnesota 55343 | 1 Holtzman Street, Science Park P.O. Box 2496 Rehovot, Israel 76124 | |||||||
| (Addresses of principal executive offices) | ||||||||
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
CONTENTS
Quarterly and Annual Results of Operations
On March 5, 2026, Stratasys Ltd. (“Stratasys”, “we” or “us”) announced its financial results for the fourth quarter and year ended December 31, 2025. A copy of our press release announcing our results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) and is incorporated herein by reference.
In conjunction with the conference call being held on March 5, 2026 to discuss our results, we are furnishing a copy of the slide presentation that provides supplemental information regarding our business and our financial results, and which will be referenced on that conference call. We have attached that presentation as Exhibit 99.2 to this Form 6-K, which exhibit is incorporated herein by reference.
The information in this Form 6-K, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Exhibits
The following exhibits are furnished as part of this Form 6-K:
| Exhibit | Description | |||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| STRATASYS LTD. | ||||||||
Dated: March 5, 2026 | By: | /s/ Eitan Zamir | ||||||
| Name: | Eitan Zamir | |||||||
| Title: | Chief Financial Officer | |||||||
Exhibit 99.1
Stratasys Releases Fourth Quarter and Full Year 2025 Financial Results
•Fourth quarter revenue of $140.0 million, compared to $150.4 million in the prior year period
•Fourth quarter GAAP net loss of $18.9 million, or $0.22 per diluted share
•Fourth quarter Non-GAAP net income of $6.2 million, or $0.07 per diluted share
•Full year revenue of $551.1 million, compared to $572.5 million in 2024
•Full year GAAP net loss of $104.3 million, or $1.28 per diluted share
•Full year Non-GAAP net income increased to $12.7 million, or $0.15 per diluted share, over prior year $4.2 million or $0.06, respectively
•Fourth quarter positive operating cash flow of $4.8 million
•Full year positive operating cash flow of $15.1 million
•Strong balance sheet with $244.5 million cash, equivalents and short-term deposits and no debt at year-end 2025
•Fourth quarter Adjusted EBITDA of $9.2 million, 6.6% of revenue
•Full year Adjusted EBITDA grew 9.6% to $28.5 million, 5.2% of revenue, compared to $26.0 million, 4.5% of revenue in 2024
•Provides 2026 outlook
MINNETONKA, Minn. & REHOVOT, Israel - (BUSINESS WIRE) - March 5, 2026 - Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced financial results for the fourth quarter and full year 2025.
Dr. Yoav Zeif, Stratasys' Chief Executive Officer, stated, “Our fourth quarter performance caps a year in which we successfully maintained our operational discipline and delivered solid cash flow generation, demonstrating the resilience that distinguishes Stratasys. We generated 37.5% of our revenues from manufacturing applications, up from 25% in 2020, and made meaningful progress building on the foundational infrastructure of our highest-value use-cases, as we continued to improve our position in aerospace and defense, automotive tooling, dental, and medical applications.”
Dr. Zeif continued, “As we enter 2026, we do so with proven operational excellence, strategic clarity, and the technology portfolio to capitalize on the inevitable return of customer spending. Our commitment to innovation remains unwavering, supported by continued R&D investment and strategic partnerships that provide complete end-to-end solutions. Combined with our strong balance sheet, this positions us to capitalize on inorganic opportunities that we continue to explore, to sustain our technology leadership through strategic investments that will define the next era of digital manufacturing. The stage is set for sustained growth, as customers achieve measurable operational
1
improvements and increase their utilization in true production-scale manufacturing for mission-critical applications.”
Summary - Fourth Quarter 2025 Financial Results Compared to Fourth Quarter 2024:
•Revenue of $140.0 million compared to $150.4 million.
•GAAP gross margin of 36.8%, compared to 46.3%.
•Non-GAAP gross margin of 46.3%, compared to 49.6%.
•GAAP operating loss of $20.8 million, compared to an operating loss of $9.7 million.
•Non-GAAP operating income of $4.1 million, compared to operating income of $9.4 million.
•GAAP net loss of $18.9 million, or $0.22 per diluted share, compared to a net loss of $41.9 million, or $0.59 per diluted share.
•Non-GAAP net income of $6.2 million, or $0.07 per diluted share, compared to net income of $8.5 million, or $0.12 per diluted share.
•Adjusted EBITDA of $9.2 million, compared to $14.5 million.
•Cash provided by operating activities of $4.8 million, compared to $7.4 million.
Summary - 2025 Financial Results Compared to 2024:
•Revenue of $551.1 million compared to $572.5 million.
•GAAP gross margin of 41.2%, compared to 44.9%.
•Non-GAAP gross margin of 46.9%, compared to 49.2%.
•GAAP operating loss of $72.5 million, compared to an operating loss of $85.7 million.
•Non-GAAP operating income of $8.3 million, compared to operating income of $4.9 million.
•GAAP net loss of $104.3 million, or $1.28 per diluted share, compared to a loss of $120.3 million, or $1.70 per diluted share.
•Non-GAAP net income of $12.7 million, or $0.15 per diluted share, compared to net income of $4.2 million, or $0.06 per diluted share.
•Adjusted EBITDA of $28.5 million, compared to $26.0 million.
•Cash generated by operating activities of $15.1 million, compared to $7.8 million.
Financial Outlook:
Based on current market conditions and assuming that the impacts of global inflationary pressures, relatively high interest rates, increased tariffs and other supply chain costs do not impede economic activity further, the Company is providing the following outlook for 2026, which includes an assumption of $17 million of combined adverse impact from exchange rates and tariffs relative to 2025:
•Full year revenue growing to $565 million to $575 million, improving sequentially through the year.
2
•Based on current logistics and materials costs, full year non-GAAP gross margins of 46.7%-47.1%, including approximately $7 million of adverse impact from tariffs and foreign exchange rates relative to 2025.
•Full year non-GAAP operating expenses ranging from $260 million to $262 million, including approximately $10 million of adverse impact from changes in foreign exchange rates.
•Full year non-GAAP operating margins in a range of 0.7% to 1.5%.
•GAAP net loss of $83 million to $67 million, or ($0.95) to ($0.76) per diluted share.
•Non-GAAP net income of $8 million to $12.5 million, or $0.09 to $0.14 per diluted share.
•Adjusted EBITDA of $25 million to $30 million, reflecting Adjusted EBITDA margin of 4.5% to 5.0%.
•Capital expenditures of $20 million to $25 million.
•Expects to generate positive operating cash flow subject to uncertainty around foreign exchange rates and tariffs.
Appropriate reconciliations between historical GAAP and non-GAAP financial measures, as well as between the GAAP and non-GAAP financial measures included in our financial outlook for 2026, are provided in the tables at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures. [We have not included, however, guidance for GAAP gross margin or a reconciliation of our guidance for non-GAAP gross margins to the most directly comparable GAAP financial measure (i.e., GAAP gross margin), as we are unable to do so without unreasonable effort or with reasonable certainty from a quantitative perspective.]
Stratasys Ltd. Fourth Quarter 2025 Webcast and Conference Call Details
The Company plans to webcast its conference call to discuss its fourth quarter and full-year 2025 financial results on Thursday, March 5, 2026, at 8:30 a.m. (ET).
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=E1fXyUKp
To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.
Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.
To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X/Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation
3
FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.
Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2026 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the extent of our success at introducing new or improved products and solutions that gain market share; the extent of growth of the 3D printing market generally; the global macro-economic environment, including the impact of increased import tariffs that have been imposed by the U.S. and other countries; global trends involving inflation, interest rates, economic activity and currency exchange rates, and their impact on the additive manufacturing industry, our company and our customers, in particular; changes in our overall strategy, including as related to any restructuring activities and our capital expenditures; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the potential adverse impact of global interruptions and delays involving freight carriers and other third parties on our supply chain and distribution network; global market, political and economic conditions, and in the countries in which we operate in particular; potential adverse effects of Israel’s recent preemptive or retaliatory wars against Iran and its sponsored terrorist organizations Hamas (in Gaza), Hezbollah (in Lebanon), and, intermittently, the Houthis (in Yemen); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2025, to be filed with the U.S. Securities and Exchange Commission, or SEC, on or about the date hereof (the “2025 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2025 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2026, which have been or will be furnished to the SEC throughout 2026, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
4
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, but not limited, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations. Our management utilizes these non-GAAP measures to enable us to assess our financial results (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions, (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items, (iii) for certain non-GAAP measures, after eliminating the impact of changes attributable to currency exchange rate fluctuations, and (iv) after excluding changes in revenues solely attributable to divestitures of former subsidiary companies. The items eliminated as part of our calculation of our non-GAAP financial measures either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. Our non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between the GAAP and non-GAAP bases upon which we present our results and financial outlook is provided in the tables below.
Yonah Lloyd
CCO & VP Investor Relations
Yonah.Lloyd@stratasys.com
Source: Stratasys Ltd.
5
Stratasys Ltd.
| Consolidated Balance Sheets | ||||||||||||||
| (U.S. $ in thousands, except share data) | ||||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||
| ASSETS | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ | 94,527 | $ | 70,200 | ||||||||||
Short-term bank deposits | 150,000 | 80,500 | ||||||||||||
| Accounts receivable, net of allowance for credit losses of $4,145 and $3,058 as of December 31, 2025 and 2024, respectively | 160,478 | 152,979 | ||||||||||||
| Inventories | 145,238 | 179,809 | ||||||||||||
| Prepaid expenses | 5,500 | 7,630 | ||||||||||||
| Other current assets | 26,241 | 21,843 | ||||||||||||
| Total current assets | 581,984 | 512,961 | ||||||||||||
| Non-current assets | ||||||||||||||
| Property, plant and equipment, net | 192,566 | 184,379 | ||||||||||||
| Goodwill | 101,599 | 99,082 | ||||||||||||
| Other intangible assets, net | 95,842 | 106,253 | ||||||||||||
| Operating lease right-of-use assets | 25,417 | 32,169 | ||||||||||||
| Long-term investments | 63,104 | 80,205 | ||||||||||||
| Other non-current assets | 13,252 | 14,697 | ||||||||||||
| Total non-current assets | 491,780 | 516,785 | ||||||||||||
| Total assets | $ | 1,073,764 | $ | 1,029,746 | ||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities | ||||||||||||||
| Accounts payable | $ | 43,021 | $ | 44,977 | ||||||||||
| Accrued expenses and other current liabilities | 34,284 | 39,749 | ||||||||||||
| Accrued compensation and related benefits | 31,304 | 29,206 | ||||||||||||
Deferred revenues - short-term | 47,835 | 46,347 | ||||||||||||
| Operating lease liabilities - short-term | 6,597 | 6,935 | ||||||||||||
| Total current liabilities | 163,041 | 167,214 | ||||||||||||
| Non-current liabilities | ||||||||||||||
| Deferred revenues - long-term | 19,062 | 19,057 | ||||||||||||
Deferred income taxes | 312 | 507 | ||||||||||||
| Operating lease liabilities - long-term | 19,903 | 25,155 | ||||||||||||
Contingent consideration - long-term | 5,353 | 4,933 | ||||||||||||
| Other non-current liabilities | 23,193 | 19,889 | ||||||||||||
| Total non-current liabilities | 67,823 | 69,541 | ||||||||||||
| Total liabilities | $ | 230,864 | $ | 236,755 | ||||||||||
Commitments and contingencies (see note 11) | ||||||||||||||
| Equity | ||||||||||||||
| Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 86,376 thousands shares and 71,982 thousands shares issued at December 31, 2025 and 2024, respectively; 86,110 thousands shares and 71,716 thousands shares outstanding at December 31, 2025 and 2024, respectively | $ | 242 | $ | 202 | ||||||||||
| Treasury shares at cost, 266 thousands shares at December 31, 2025 and 2024 | (1,995) | (1,995) | ||||||||||||
| Additional paid-in capital | 3,275,344 | 3,123,024 | ||||||||||||
| Accumulated other comprehensive loss | (6,197) | (8,031) | ||||||||||||
| Accumulated deficit | (2,424,494) | (2,320,209) | ||||||||||||
| Total equity | 842,900 | 792,991 | ||||||||||||
| Total liabilities and equity | $ | 1,073,764 | $ | 1,029,746 | ||||||||||
Stratasys Ltd.
Consolidated Statements of Operations | ||||||||||||||||||||||||||
(U.S. $ in thousands, except per share data) | Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Revenues | ||||||||||||||||||||||||||
| Products | $ | 97,622 | $ | 105,035 | $ | 380,269 | $ | 391,917 | ||||||||||||||||||
| Services | 42,378 | 45,324 | 170,833 | 180,541 | ||||||||||||||||||||||
| 140,000 | 150,359 | 551,102 | 572,458 | |||||||||||||||||||||||
| Cost of revenues | ||||||||||||||||||||||||||
| Products | 60,782 | 53,587 | 206,475 | 197,807 | ||||||||||||||||||||||
| Services | 27,757 | 27,083 | 117,341 | 117,835 | ||||||||||||||||||||||
| 88,539 | 80,670 | 323,816 | 315,642 | |||||||||||||||||||||||
| Gross profit | 51,461 | 69,689 | 227,286 | 256,816 | ||||||||||||||||||||||
| Operating expenses | ||||||||||||||||||||||||||
| Research and development, net | 18,030 | 24,785 | 77,304 | 99,142 | ||||||||||||||||||||||
| Selling, general and administrative | 54,192 | 54,604 | 222,471 | 243,335 | ||||||||||||||||||||||
| 72,222 | 79,389 | 299,775 | 342,477 | |||||||||||||||||||||||
| Operating loss | (20,761) | (9,700) | (72,489) | (85,661) | ||||||||||||||||||||||
| Financial income, net | 2,971 | 176 | 10,386 | 1,676 | ||||||||||||||||||||||
| Loss before income taxes | (17,790) | (9,524) | (62,103) | (83,985) | ||||||||||||||||||||||
| Income tax expenses | 1,062 | 653 | 3,082 | 2,973 | ||||||||||||||||||||||
| Share in losses of associated companies and impairment charges | — | 31,766 | 39,100 | 33,325 | ||||||||||||||||||||||
| Net loss | $ | (18,852) | $ | (41,943) | $ | (104,285) | $ | (120,283) | ||||||||||||||||||
| Net loss per share - basic and diluted | $ | (0.22) | $ | (0.59) | $ | (1.28) | $ | (1.70) | ||||||||||||||||||
| Weighted average ordinary shares outstanding - basic and diluted | 85,671 | 71,406 | 81,602 | 70,858 | ||||||||||||||||||||||
Stratasys Ltd.
| Reconciliation of GAAP to Non-GAAP Results of Operations | |||||||||||||||||||||||
| Three Months Ended December 31, | |||||||||||||||||||||||
| 2025 | Non-GAAP | 2025 | 2024 | Non-GAAP | 2024 | ||||||||||||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | ||||||||||||||||||
| U.S. dollars and shares in thousands (except per share amounts) | |||||||||||||||||||||||
| Gross profit (1) | $ | 51,461 | $ | 13,393 | $ | 64,854 | $ | 69,689 | $ | 4,866 | $ | 74,555 | |||||||||||
| Operating income (loss) (1,2) | (20,761) | 24,853 | 4,092 | (9,700) | 19,144 | 9,444 | |||||||||||||||||
| Net income (loss) (1,2,3) | (18,852) | 25,034 | 6,182 | (41,943) | 50,462 | 8,519 | |||||||||||||||||
| Net income (loss) per diluted share (4) | $ | (0.22) | $ | 0.29 | $ | 0.07 | $ | (0.59) | $ | 0.71 | $ | 0.12 | |||||||||||
| (1) | Acquired intangible assets amortization expenses | 4,749 | 4,496 | ||||||||||||||||||||
| Non-cash share-based compensation expenses | 772 | 198 | |||||||||||||||||||||
| Restructuring and other expenses | 7,872 | 172 | |||||||||||||||||||||
| 13,393 | 4,866 | ||||||||||||||||||||||
| (2) | Acquired intangible assets amortization expenses | 1,198 | 1,153 | ||||||||||||||||||||
| Non-cash share-based compensation expenses | 5,516 | 2,856 | |||||||||||||||||||||
| Restructuring and other related costs | 1,263 | 5,275 | |||||||||||||||||||||
| Revaluation of investment | — | 4,697 | |||||||||||||||||||||
| Contingent consideration | 436 | (9,148) | |||||||||||||||||||||
Net loss from sale of investment | — | 4,760 | |||||||||||||||||||||
| Legal and other expenses | 3,047 | 4,685 | |||||||||||||||||||||
| 11,460 | 14,278 | ||||||||||||||||||||||
| 24,853 | 19,144 | ||||||||||||||||||||||
| (3) | Corresponding tax effect | 558 | 535 | ||||||||||||||||||||
| Equity method related expenses and impairment | — | 30,910 | |||||||||||||||||||||
Finance income | (377) | (127) | |||||||||||||||||||||
| $ | 25,034 | $ | 50,462 | ||||||||||||||||||||
| (4) | Weighted average number of ordinary shares outstanding - Diluted | 85,671 | 86,311 | 71,406 | 71,740 | ||||||||||||||||||
Stratasys Ltd.
| Twelve Months Ended December 31, | |||||||||||||||||||||||
| 2025 | Non-GAAP | 2025 | 2024 | Non-GAAP | 2024 | ||||||||||||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | ||||||||||||||||||
| U.S. dollars and shares in thousands (except per share amounts) | |||||||||||||||||||||||
| Gross profit (1) | $ | 227,286 | $ | 31,097 | $ | 258,383 | $ | 256,816 | $ | 24,948 | $ | 281,764 | |||||||||||
| Operating income (loss) (1,2) | (72,489) | 80,820 | 8,331 | (85,661) | 90,594 | 4,933 | |||||||||||||||||
Net income (loss) (1,2,3) | (104,285) | 117,000 | 12,715 | (120,283) | 124,520 | 4,237 | |||||||||||||||||
| Net income (loss) per diluted share (4) | $ | (1.28) | $ | 1.43 | $ | 0.15 | $ | (1.70) | $ | 1.76 | $ | 0.06 | |||||||||||
| (1) | Acquired intangible assets amortization expenses | 18,280 | 18,576 | ||||||||||||||||||||
| Non-cash share-based compensation expenses | 3,045 | 3,072 | |||||||||||||||||||||
Restructuring and other expenses | 9,772 | 3,300 | |||||||||||||||||||||
| 31,097 | 24,948 | ||||||||||||||||||||||
| (2) | Acquired intangible assets amortization expenses | 4,121 | 5,847 | ||||||||||||||||||||
| Non-cash share-based compensation expenses | 21,229 | 22,546 | |||||||||||||||||||||
| Restructuring and other related costs | 5,494 | 17,419 | |||||||||||||||||||||
Revaluation of investments | 2,208 | 6,597 | |||||||||||||||||||||
| Contingent consideration | 1,724 | (7,595) | |||||||||||||||||||||
Net loss from sale of investment | — | 4,760 | |||||||||||||||||||||
| Legal and other expenses | 14,947 | 16,072 | |||||||||||||||||||||
| 49,723 | 65,646 | ||||||||||||||||||||||
| 80,820 | 90,594 | ||||||||||||||||||||||
| (3) | Corresponding tax effect | 1,015 | 1,267 | ||||||||||||||||||||
| Equity method related expenses and impairment | 36,245 | 31,262 | |||||||||||||||||||||
| Finance expenses (income) | (1,080) | 1,397 | |||||||||||||||||||||
| $ | 117,000 | $ | 124,520 | ||||||||||||||||||||
| (4) | Weighted average number of ordinary shares outstanding - Diluted | 81,602 | 82,301 | 70,858 | 71,177 | ||||||||||||||||||
Stratasys Ltd.
| Reconciliation of GAAP net loss to Adjusted EBITDA | |||||||||||||||||||||||
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| U.S. $ in thousands | U.S. $ in thousands | ||||||||||||||||||||||
| Net loss | $ | (18,852) | $ | (41,943) | $ | (104,285) | $ | (120,283) | |||||||||||||||
| Financial income, net | (2,971) | (176) | (10,386) | (1,676) | |||||||||||||||||||
| Income tax expenses | 1,062 | 653 | 3,082 | 2,973 | |||||||||||||||||||
| Share in losses of associated companies and impairment charges | — | 31,766 | 39,100 | 33,325 | |||||||||||||||||||
Depreciation expenses | 5,190 | 5,033 | 20,738 | 21,030 | |||||||||||||||||||
Amortization expenses | 5,954 | 5,649 | 22,435 | 24,423 | |||||||||||||||||||
| Non-cash share-based compensation expenses | 6,288 | 3,054 | 24,274 | 25,618 | |||||||||||||||||||
| Revaluation of investments | — | 4,697 | 2,208 | 6,597 | |||||||||||||||||||
Net loss from sale of investment | — | 4,760 | — | 4,760 | |||||||||||||||||||
| Contingent consideration | 436 | (9,148) | 1,724 | (7,595) | |||||||||||||||||||
| Legal and other expenses | 3,915 | 4,685 | 15,935 | 16,072 | |||||||||||||||||||
| Restructuring and other expenses | 8,155 | 5,447 | 13,695 | 20,719 | |||||||||||||||||||
| Adjusted EBITDA | $ | 9,177 | $ | 14,477 | $ | 28,520 | $ | 25,963 | |||||||||||||||
Stratasys Ltd.
| Reconciliation of GAAP Net Loss to Non-GAAP Net Income Forward Looking Guidance: | |||||||||||||||||
Fiscal Year 2026 | |||||||||||||||||
| (U.S. $ in millions, except per share data) | Low | High | |||||||||||||||
| GAAP net loss | $(83) | to | $(67) | ||||||||||||||
| Adjustments | |||||||||||||||||
| Share-based compensation expenses | $24 | to | $26 | ||||||||||||||
| Intangible assets amortization expenses | $23 | to | $25 | ||||||||||||||
| Reorganization and other | $31 | to | $37 | ||||||||||||||
Tax expenses related to Non-GAAP adjustments | $2 | to | $3 | ||||||||||||||
| Non-GAAP net income | $8 | to | $13 | ||||||||||||||
| GAAP loss per share | $(0.95) | to | $(0.76) | ||||||||||||||
| Non-GAAP diluted earnings per share | $0.09 | to | $0.14 | ||||||||||||||
| Reconciliation of GAAP Net Loss to Adjusted EBITDA Forward Looking Guidance: | |||||||||||||||||
Fiscal Year 2026 | |||||||||||||||||
| (U.S. $ in millions, except per share data) | Low | High | |||||||||||||||
| GAAP net loss | $(83) | to | $(67) | ||||||||||||||
| Adjustments | |||||||||||||||||
| Share-based compensation expenses | $24 | to | $26 | ||||||||||||||
| Intangible assets amortization expenses | $23 | to | $25 | ||||||||||||||
| Reorganization and other | $31 | to | $37 | ||||||||||||||
Tax expenses related to Non-GAAP adjustments | $2 | to | $3 | ||||||||||||||
Other non-operating income | $(4) | to | $(4) | ||||||||||||||
| Depreciation | $21 | to | $21 | ||||||||||||||
| Adjusted EBITDA | $25 | to | $30 | ||||||||||||||
Stratasys Ltd.
| Reconciliation of GAAP Operating Loss to Non-GAAP Operating Income Forward Looking Guidance: | |||||||||||||||||
Fiscal Year 2026 | |||||||||||||||||
| (U.S. $ in millions, except per share data) | Low | High | |||||||||||||||
| GAAP operating loss | $(84) | to | $(69) | ||||||||||||||
| GAAP operating margins | (15)% | to | (12)% | ||||||||||||||
| Adjustments | |||||||||||||||||
| Share-based compensation expenses | $24 | to | $26 | ||||||||||||||
| Intangible assets amortization expenses | $23 | to | $25 | ||||||||||||||
| Reorganization and other | $31 | to | $37 | ||||||||||||||
| Non-GAAP operating profit | $4 | to | $8.5 | ||||||||||||||
| Non-GAAP operating margins | 0.7% | to | 1.5% | ||||||||||||||
Make additive work for you Q4 and FY 2025 Results Speakers Dr. Yoav Zeif, CEO Eitan Zamir, CFO Yonah Lloyd, CCO & VP IR March 5, 2026
Make additive work for you Conference Call and Webcast Link US Toll-Free Dial-In 1-877-407-0619 International Dial-In +1-412-902-1012 Live Webcast and Replay
Forward-Looking Statements Cautionary Statement Regarding Forward-Looking Statements The statements in this slide presentation regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2026 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the extent of our success at introducing new or improved products and solutions that gain market share; the extent of growth of the 3D printing market generally; the global macro-economic environment, including the impact of increased import tariffs that have been imposed by the U.S. and other countries; global trends involving inflation, interest rates, economic activity and currency exchange rates, and their impact on the additive manufacturing industry, our company and our customers, in particular; changes in our overall strategy, including as related to any restructuring activities and our capital expenditures; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the potential adverse impact of global interruptions and delays involving freight carriers and other third parties on our supply chain and distribution network; global market, political and economic conditions, and in the countries in which we operate in particular; potential adverse effects of Israel’s recent preemptive or retaliatory wars against Iran and/or its sponsored terrorist organizations Hamas, Hezbollah, and, intermittently, the Houthis; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2025, to be filed with the U.S. Securities and Exchange Commission, or SEC, on or about the date of this presentation (the “2025 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2025 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2026, which will be furnished to the SEC throughout 2026, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this slide presentation are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Make additive work for you
The non-GAAP data included herein, but not limited, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations. Our management utilizes these non-GAAP measures to enable us to assess our financial results (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains and legal provisions, (ii) excluding non-cash items such as share- based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items, (iii) for certain non-GAAP measures, after eliminating the impact of changes attributable to currency exchange rate fluctuations, and (iv) after excluding changes in revenues solely attributable to divestitures of former subsidiary companies. The items eliminated as part of our calculation of our non-GAAP financial measures either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. Our non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in the tables later in this slide presentation. We have not included herein, however, a reconciliation of our non-GAAP guidance for 2026 to the most directly comparable GAAP guidance. Please see our earnings release being published today for that reconciliation (other than for our guidance for non-GAAP gross margin, as we are unable to provide either the equivalent GAAP figure (projected GAAP gross margin) or the related reconciliation without unreasonable effort or with reasonable certainty from a quantitative perspective). Make additive work for you Use of Non-GAAP Financial Information Use of Non-GAAP Financial Measures
▪ Operational discipline, solid cash flow, margins and profitability, and improving our position in focus target areas demonstrate the resilience distinguishing Stratasys. ▪ 37.5% of revenues came from MFG in 2025, up from 36% in 2024 and from just over 25% in 2020. Continued growth to drive higher margin consumables utilization. ▪ Robust, strategically focused customer engagement generated notable growth in key high-value use cases of aerospace/defense, automotive, dental and medical. ▪ Powerful megatrends of aerospace/defense budget increases, cost optimization, supply chain localization, onshoring, next-gen mobility, sustainability and mass personalization align directly with our core strengths. ▪ $9.2M EBITDA (6.6%) and $0.07 Adj. EPS in Q4. Confident that proven operational efficiencies will result in sustainably higher profitability in the coming years. ▪ Healthy balance sheet of $244.5 million in cash, equivalents, and no debt provides stability and optionality to grow through organic investments and accretive acquisition opportunities. ▪ World leader in industrial polymer 3D printing for high-requirement use cases, providing comprehensive solutions that include innovative, reliable hardware, the largest portfolio of materials, award-winning software, post-processing, and a full suite of service and support, for complete, end-to-end workflow solutions. CEO Dr. Yoav Zeif
Customer Success – Aerospace & Defense – Largest Contributing Target Sector Make additive work for you ▪ Airbus – Transformational Partnership ‒ Produced over 25,000 flight-ready parts in 2025, total certified active Stratasys parts now 200,000+. True production-scale AM delivers 43% weight reduction, 85% lead time reduction, and eliminates MOQs, enabling distributed MFG and reducing downtime and supply chain risk. ▪ Commercial Aerospace Leaders – Expansion for Manufacturing ‒ Boeing's 737 Innovation Center purchased two F3300 printers for production tooling. ‒ Leading aircraft manufacturer acquired two F900’s for flight-grade parts, increasing total Stratasys fleet to nine. ▪ Drones Drive Military Opportunities ‒ Systems sales to several major drone companies for parts production and wind tunnel testing; expanded demand from non-traditional defense primes in unmanned and space sectors. ‒ Top-three 2025 Stratasys Direct customers are large military drone suppliers. ‒ Multiple F3300/F900 systems for flight-grade parts spanning startups to traditional primes with high adoption of premium service contracts, demonstrates AM mainstreaming across aviation.
Make additive work for you Subaru of America ▪ One of the first to Implement new T25 high speed head for the F770 printer. ▪ Achieving over 50% reduction in tooling development time, 70% cost reduction and nearly twice the printing speed. ▪ Breakthrough enables Subaru to consolidate production in- house, improving repeatability while reducing reliance on outsourced manufacturing. Customer Success – Automotive Expansion and F1 Championship Rivian ▪ Extensive deployment of 28 Stratasys systems demonstrates our technology's scalability. ▪ F900 systems operating at over 90% utilization. ▪ F3300 delivering nearly twice the printing speed, processing 6,000 requests annually equaling tens of thousands of parts used in product development, tooling and production. McLaren F1 ▪ Proud to congratulate our partner McLaren F1 on winning the 2025 Constructors' and Drivers' Championships. ▪ McLaren leveraged our SLA, FDM, and PolyJet to support race-winning innovation. ▪ Auto OEMs are integrating Stratasys into production workflows, from Formula 1 racing innovation to EV manufacturing, positioning us strongly within the rapidly evolving automotive market.
Make additive work for you Novineer ▪ Leading generative modeling, design and simulation company integrating NoviPath technology into GrabCAD Print Pro, creating the industry's first complete validated FDM workflow. ▪ Eliminates costly trial-and-error testing, reducing validation time from weeks to hours, up to 35% weight reductions. ▪ Positions Stratasys as the production-ready additive manufacturing leader across F3300, F900, and Fortus 450mc. Partnerships in Software, Workflow & Go-To-Market PostProcess ▪ PostProcess revolutionizing AM with the only automated, intelligent PP for printed parts. ▪ Enables customers to purchase validated PP equipment through a single Stratasys order. ▪ Simplifies procurement, reduces risk, addresses complexity by providing an integrated solution guaranteeing compatibility with FDM, PolyJet, SLA, and P3 to capture more value across the entire AM workflow. Hawk Ridge Systems ▪ Leading, award-winning provider of AM engineering and MFG tools, technology, services and training in the U.S. and Canada. ▪ Expands market reach by adding PolyJet, SLA and P3 to target aerospace, automotive, medical, and industrial sectors. ▪ Leverages Hawk Ridge's application expertise and customer proximity to accelerate adoption, strengthen sales and drive momentum of our industrial solutions.
Medical Advisory Board – Building on Industrial Advisory Board Success Make additive work for you ▪ New Medical Advisory Board (MAB) builds on success of Industrial Customer Advisory Board (CAB) of fourteen leaders such as Boeing, Toyota, Lockheed-Martin and TE Connectivity, to deepen innovation and collaboration to advance additive manufacturing at scale. ▪ MAB convenes clinical and Medtech experts to accelerate the adoption of AM in healthcare, focusing on the unique requirements of medical-grade applications, regulatory alignment, and patient outcomes. ▪ Initial members include eight senior executives from leading medical technology companies such as Medtronic, the world’s largest medical device manufacturer, and Edwards Lifesciences, a global leader in structural heart disease and critical care technologies, alongside other organizations spanning pharmaceuticals, cardiology, orthopedics, and clinical education.
CFO Eitan Zamir • Fourth quarter results underscore operational discipline and financial resilience in 2025. • 2025 delivered positive adjusted operating income and EBITDA, strong OCF generation, and solid adjusted EPS despite persistent revenue headwinds and margin pressures that characterized the year. • Performance reflects sustained benefits of cost control initiatives implemented in mid-2024, now fully embedded in operating model, as well as our team's continued focus on execution and efficiency. • Diversification of revenue streams continues to provide stability through the cycle and distinguishes our financial profile relative to peers in the sector. • As we look to 2026 we remain committed to maintaining operational rigor while preserving the strategic investments necessary to sustain our technology leadership position.
Quarterly Trend 105.1 93.8 94.8 94.1 97.6 45.3 42.2 43.3 42.9 42.4 150.4 136.0 138.1 137.0 140.0 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Product Service Q4 2025 Revenue Note: $ in millions unless noted otherwise. All numbers and percentages rounded. Make additive work for you Revenues – Q4’25 Revenue Y/Y Product - $97.6M -7.1% ▪ Systems - $37.8M -19.1% ▪ Consumables - $59.8M 2.4% Services - $42.4M -6.4% ▪ Customer Support - $29.6M -3.3%
Revenues – 2025 Revenue Y/Y Product - $380.3M -3.0% ▪ Systems - $131.6M -6.2% ▪ Consumables - $248.7M -1.2% Services - $170.8M -5.4% ▪ Customer Support - $119.0M -4.6% FY 2025 Revenue Make additive work for you Yearly Trend 417.6 452.1 433.7 392.0 380.3 189.7 199.4 193.9 180.5 170.8 2021 2022 2023 2024 2025 Product Service * ** * Reflects ~$26M of MakerBot revenue. Excluding divestment, 2022 revenues of ~$625.5M ** Reflects ~$18M of SDM divested revenue. Excluding divestment, 2023 revenues of ~$609.8M Note: $ in millions unless noted otherwise. All numbers and percentages rounded 551.1572.5 627.6 651.5 607.2
GAAP Non-GAAP 49.6% 48.3% 47.7% 45.3% 46.3% 53.4% 54.7% 54.3% 52.4% 50.2% 40.7% 33.9% 33.1% 29.7% 37.4% Q4-24 Q1-25 Q2-25 Q3-25 Q4-25 Services Gross MarginProducts Gross Margin Total Gross Margin Make additive work for you Note: All percentages rounded. Q4 2025 Gross Margins 49.0% 49.6% 48.7% 47.0% 37.7% 40.2% 32.5% 30.8% 27.6% 34.5% 46.3% 44.3% 43.1% 41.0% 36.8% Q4-24 Q1-25 Q2-25 Q3-25 Q4-25
GAAP Non-GAAP 47.8% 48.0% 48.2% 49.2% 46.9% 56.3% 54.7% 52.8% 54.9% 52.9% 29.3% 32.7% 38.1% 36.9% 33.5% 2021 2022 2023 2024 2025 Services Gross MarginProducts Gross Margin Total Gross Margin Make additive work for you Note: All percentages rounded. FY 2025 Gross Margins 49.5% 48.1% 47.8% 49.5% 45.7% 28.2% 29.6% 30.8% 34.7% 31.3% 42.8% 42.4% 42.5% 44.9% 41.2% 2021 2022 2023 2024 2025
GAAP Operating Expenses (absolute and as a percentage of revenues) Non-GAAP Operating Expenses (absolute and as a percentage of revenues) 79.4 72.2 51.6% Q4'24 Q4'25 52.8% 65.2 60.8 Q4'24 Q4'25 43.4% 43.4% Note: $ in millions unless noted otherwise. All numbers and percentages rounded. Make additive work for you Q4 2025 Operating Expenses - Significant improvement driven by cost saving initiatives
GAAP Operating Expenses (absolute and as a percentage of revenues) Non-GAAP Operating Expenses (absolute and as a percentage of revenues) 2024 2025 342.5 59.8% 54.4% Note: $ in millions unless noted otherwise. All numbers and percentages rounded. FY 2025 Operating Expenses Make additive work for you 299.8 2024 2025 276.8 250.1 45.4% 48.4% 276.8 250.1 342.5 299.8
(41.9) )18.9( (20.8) Non-GAAP Operating Income 6.3% in Q4’24 vs 2.9% in Q4’25 out of total revenue GAAP Operating Loss Non-GAAP Net Income EPS diluted $0.12 in Q4’24 vs $0.07 in Q4’25 GAAP Net Loss* EPS diluted ($0.59) in Q4’24 vs ($0.22) in Q4’25 Q4’24 Q4’25 9.214.5 6.2 Adjusted EBITDA 9.6% in Q4’24 vs 6.6% in Q4’25 out of total revenue 9.4 4.1 8.5 Q4’24 Q4’25 Q4’24 Q4’25 Q4’24 Q4’25 Q4’24 Q4’25 (9.7) Q4 2025 Operating, Net and EBITDA *For Q4’24, reflects non-cash impairment charge of $30.1M, or $0.42 per share, related to Ultimaker investment. Note: $ in millions, except per share amounts unless noted otherwise. All numbers and percentages rounded. Make additive work for you
(120.3) (104.3) (72.5) Non-GAAP Operating Income 0.9% in 2024 vs 1.5% in 2025 out of total revenue GAAP Operating Loss Non-GAAP Net Income EPS diluted $0.06 in 2024 vs $0.15 in 2025 GAAP Net Loss* EPS diluted ($1.70) in 2024 vs ($1.28) in 2025 2024 2025 28.526.0 12.7 Adjusted EBITDA 4.5% in 2024 vs 5.2% in 2025 out of total revenue 4.9 8.3 4.2 2024 2025 2024 2025 2024 2025 2024 2025 (85.7) FY 2025 Operating, Net and EBITDA - Operational efficiencies drive improved profitability *For 2024 and 2025, reflects non-cash impairment charge of $30.1M, or $0.42 and $33.9, or $0.40 per share, respectively, related to Ultimaker investment. Note: $ in millions, except per share amounts unless noted otherwise. All numbers and percentages rounded. Make additive work for you
Balance Sheet ItemsCash Flow from Operating Activities 19 7.4 4.8 7.8 15.1 Q4-24 Q4-25 2024 2025 Note: $ in millions unless noted otherwise. All numbers and percentages rounded. Make additive work for you Strong Balance Sheet – $244.5M and No Debt Q4-24 Q3-25 Q4-25 Cash and Cash Equivalents and Short- term deposits 150.7 255.0 244.5 Accounts Receivable 153.0 151.3 160.5 Inventories 179.8 159.3 145.2 Net Working Capital 345.7 438.4 418.9
Revenues Non-GAAP Operating Expenses Includes ~$10M adverse impact from FX Non-GAAP Operating Margins Adjusted Net Income Adjusted EPS diluted GAAP Net loss ($83M) - ($67M) GAAP EPS ($0.95) - ($0.76) CAPEX Adjusted EBITDA 4.5% - 5.0% of Revenue Includes ~$17M adverse impact from FX & Tariffs $565M – $575M 46.7% – 47.1% $260M – $262M $20M – $25M$25M – $30M0.7% – 1.5% Positive Operating Cash Flow for 2026 Subject to foreign exchange rate and tariff uncertainty 2026 Full-Year Outlook $8M – $12.5M $0.09 – $0.14 Make additive work for you Non-GAAP Gross Margins Includes ~$7M adverse impact from FX & Tariffs
CEO Dr. Yoav Zeif Growing in High-Requirement Sectors ▪ Confident in executing through challenging conditions to preserve our capacity to lead and increase profits when market dynamics improve. ▪ Progress in target industries of aerospace/defense, auto, dental, medical and precision industrial components reinforces our conviction that we built the infrastructure for durable, profitable growth. ▪ Margin discipline, operational resilience, strong balance sheet protects profitability, positions us to capitalize on inorganic opportunities we continue to explore, and sustains our leadership through strategic investments in innovation defining the next era of digital manufacturing. ▪ Deepening penetration into high-value production applications as we remain committed to maximizing long-term shareholder value. ▪ Global team’s dedication, professionalism, and customer focus drives engagement and trust, positioning Stratasys for sustained leadership. Make additive work for you
Make additive work for you THANK YOU
23 Note: $ in millions, except per share amounts unless noted otherwise. All numbers and percentages rounded. 23 Appendix – Comparison of Q4 2025 to Q4 2024 Key Metrics Make additive work for you GAAP Non-GAAP Q4-24 Q4-25 Change Y/Y Q4-24 Q4-25 Change Y/Y Total Revenue 150.4 140.0 -6.9% 150.4 140.0 -6.9% Gross Profit 69.7 51.5 (18.2) 74.6 64.9 (9.7) ▪% Margin 46.3% 36.8% -9.5% 49.6% 46.3% -3.3% Operating Income (Loss) (9.7) (20.8) (11.1) 9.4 4.1 (5.3) ▪% Margin -6.4% -14.9% -8.5% 6.3% 2.9% -3.4% Net Income (Loss) (41.9) (18.9) 23.0 8.5 6.2 (2.3) ▪% Margin -27.9% -13.5% 14.4% 5.7% 4.4% -1.3% Diluted EPS (0.59) (0.22) 0.37 0.12 0.07 (0.05) Diluted Shares 71.4 85.7 14.3 71.7 86.3 14.6
24 Note: $ in millions, except per share amounts unless noted otherwise. All numbers and percentages rounded. 24 Appendix – Comparison of 2025 to 2024 Key Metrics Make additive work for you GAAP Non-GAAP 2024 2025 Change Y/Y 2024 2025 Change Y/Y Total Revenue 572.5 551.1 -3.7% 572.5 551.1 -3.7% Gross Profit 256.8 227.3 (29.5) 281.8 258.4 (23.4) ▪% Margin 44.9% 41.2% -3.7% 49.2% 46.9% -2.3% Operating Income (Loss) (85.7) (72.5) 13.2 4.9 8.3 3.4 ▪% Margin -15.0% -13.2% 1.8% 0.9% 1.5% 0.6% Net Income (Loss) (120.3) (104.3) 16.0 4.2 12.7 8.5 ▪% Margin -21.0% -18.9% 2.1% 0.7% 2.3% 1.6% Diluted EPS (1.70) (1.28) 0.42 0.06 0.15 0.09 Diluted Shares 70.9 81.6 10.7 71.2 82.3 11.1
Note: $ in thousands unless noted otherwise. All numbers and percentages rounded. Appendix – Reconciliation of GAAP to Non-GAAP Results of Operations GAAP Adjustments Non-GAAP GAAP Adjustments Non-GAAP Gross Profit (1) $ 51,461 $ 13,393 $ 64,854 $ 69,689 $ 4,866 $ 74,555 Operating income (loss) (1,2) (20,761) 24,853 4,092 (9,700) 19,144 9,444 Net income (loss) (1,2,3) (18,852) 25,034 6,182 (41,943) 50,462 8,519 Net income (loss) per diluted share (4) $ (0.22) $ 0.29 $ 0.07 $ (0.59) $ 0.71 $ 0.12 (1) Acquired intangible assets amortization expenses 4,749 4,496 Non-cash share-based compensation expenses 772 198 Restructuring and other expenses 7,872 172 13,393 4,866 (2) Acquired intangible assets amortization expenses 1,198 1,153 Non-cash share-based compensation expenses 5,516 2,856 Restructuring and other related costs 1,263 5,275 Revaluation of investment - 4,697 Contingent consideration 436 (9,148) Net loss from sale of investment - 4,760 Legal and other expenses 3,047 4,685 11,460 14,278 24,853 19,144 (3) Corresponding tax effect 558 535 Equity method related expenses and impairment - 30,910 Finance income (377) (127) $ 25,034 $ 50,462 (4) Weighted average number of ordinary shares outstanding- Diluted 85,671 86,311 71,406 71,740 Three Months Ended December 31, 2025 Three Months Ended December 31, 2024
Note: $ in thousands unless noted otherwise. All numbers and percentages rounded. Appendix – Reconciliation of GAAP Net Loss to Adjusted EBITDA 2025 2024 Net loss $ (18,852) $ (41,943) Financial income, net (2,971) (176) Income tax expenses 1,062 653 Equity method related expenses and impairment - 31,766 Depreciation expenses 5,190 5,033 Amortization expenses 5,954 5,649 Non-cash share-based compensation expenses 6,288 3,054 Revaluation of investment - 4,697 Net loss from sale of investment - 4,760 Contingent consideration 436 (9,148) Legal and other expenses 3,915 4,685 Restructuring and other related costs 8,155 5,447 Adjusted EBITDA $ 9,177 $ 14,477 Three Months Ended December 31,